newest glp 1 agonist A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure GLP-1 Receptor Agonists: The New

doi:10.1038/clpt.2010.184 Lyssenko V, Lupi R, Marchetti P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

Rise of Dual and Triple Agonists: Beyond GLP-1, newer drugs target GIP and glucagon receptors for enhanced efficacy (e.g., Tirzepatide, Retatrutide)

Hurtado, MD, Mayo Clinic While side effects are a common part of treatment, regular monitoring ensures the therapy remains safe and effective

These medications work through several mechanisms: Slowing gastric emptying : Food stays in your stomach longer, creating extended feelings of fullness Reducing appetite : They act on brain centers that control hunger signals Improving insulin sensitivity : They help your body use insulin more effectively Suppressing glucagon : They prevent your liver from releasing stored glucose into the bloodstream Currently available GLP-1 medications include: Also Read: 11 Essential Facts About Semaglutide The Hidden Long-Term Effects of GLP-1 Medications While the dramatic weight loss and improved blood sugar levels make headlines, several concerning long-term effects deserve more attention: 1

Although GLP-1RAs can reduce inflammatory signaling, this effect does not necessarily ensure that precursor inflow remains proportionate to ongoing NAD turnover [75, 105]

For instance, in non-insulin-treated individuals with or without T2DM, 16 weeks of pramlintide treatment led to an average weight loss of 3.7 kg and waist circumference reduction of 3.6 cm